Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Currently there is debate on whether hypoglycemia is an independent risk factor for atherosclerosis, but little attention has been paid to the effects of recovery from hypoglycemia. In normal control individuals and in people with type 1 diabetes, recovery from a 2-h induced hypoglycemia was obtained by reaching normoglycemia or hyperglycemia for another 2 h and then maintaining normal glycemia for the following 6 h. Hyperglycemia after hypoglycemia was also repeated with the concomitant infusion of vitamin C. Recovery with normoglycemia is accompanied by a significant improvement in endothelial dysfunction, oxidative stress, and inflammation, which are affected by hypoglycemia; however, a period of hyperglycemia after hypoglycemia worsens all of these parameters, an effect that persists even after the additional 6 h of normoglycemia. This effect is partially counterbalanced when hyperglycemia after hypoglycemia is accompanied by the simultaneous infusion of vitamin C, suggesting that when hyperglycemia follows hypoglycemia, an ischemia–reperfusion-like effect is produced. This study shows that the way in which recovery from hypoglycemia takes place in people with type 1 diabetes could play an important role in favoring the appearance of endothelial dysfunction, oxidative stress, and inflammation, widely recognized cardiovascular risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, these agents promote hemodynamic equilibrium,18 diminish thrombotic propensity,448 alleviate endothelial oxidative stress,449 attenuate inflammatory processes,450 and foster a favorable balance of the gut microbiota,451 all of which collectively contribute to the salutary effects of these agents in patients with AS.”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [449]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 2×
“(ACCORD) trial (18) and possibly in the Veterans Affairs Diabetes Trial (VADT) (19) and Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) (20) studies has caused concern, because intensive treatment had tripled the frequency of severe hypoglycemia.”
BackgroundCorretti, M. C., Anderson, T. J., Benjamin, E. J., Celermajer, D., Charbonneau, F., Creager, M. A., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01746-6 · Cited by 4,604
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434 · cited 1×
“in individuals with type 1 diabetes were within normal reference ranges (10), and they did not exhibit hypoglycemia unawareness, as based on the methods of Gold et al.”
MethodGold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Suh, S. W., Gum, E. T., Hamby, A. M., Chan, P. H., & Swanson, R. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30077 · Cited by 419 · cited 3×
“There is, however, evidence that free radical production rises, not only during hypoglycemia but particularly during glucose reperfusion after hypoglycemia (9).”
BackgroundResultDetection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress
Mercuri, F., Tonutti, L., Taboga, C., Ceriello, A., Assaloni, R., Motz, E., & Quagliaro, L. (2001) · Diabetologia · doi:10.1007/s001250100529 · Cited by 419 · cited 1×
“Cholesterol, triglycerides, HDL and LDL cholesterol, and plasma nitrotyrosine were measured as previously described (14).”
MethodSelf-citationCeriello, A., Ihnat, M. A., & Thorpe, J. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1824 · Cited by 413 · cited 2×
“The concept of “legacy” or “metabolic memory” is well recognized in hyperglycemia and indicates the possibility of a long-lasting deleterious effect persisting for some time after glucose normalization (23).”
BackgroundSelf-citation
Cited by
Reactive Oxygen Species in Inflammation and Tissue Injury
Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P., & Malik, A. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5149 · Cited by 4,897
“The circulating levels of ICAM-1, VCAM-1, and E-Selectin are elevated in hyperlipidemic and hyperglycemic and noninsulin-dependent diabetic-patients in direct correlation with increased oxidative stress (58, 69, 86, 313, 352).”
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Update on the treatment of type 2 diabetes mellitus
Marín-Peñalver, J. J., Martín-Timón, I., Sevillano-Collantes, C., & Cañizo-Gómez, F. J. D. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.354 · Cited by 647
Glycaemic variability in diabetes: clinical and therapeutic implications
Ceriello, A., Monnier, L., & Owens, D. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30136-0 · Cited by 588
Self-citationPapachristoforou, E., Lambadiari, V., Maratou, E., & Makrilakis, K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7489795 · Cited by 479
“leads to deterioration of endothelial function and rising oxidative stress and inflammation both in healthy control individuals and patients with type 1 diabetes (T1D), but not when recovery from hypoglycemia is followed by normoglycemia [171].”
BackgroundCeriello, A., Novials, A., Ortega, E., Canivell, S., La Sala, L., Pujadas, G., Esposito, K., Giugliano, D., & Genovese, S. (2013) · Diabetes Care · doi:10.2337/dc12-2469 · Cited by 204
“Finally, recent findings suggest that hypoglycemia, a frequent event in type 1 diabetes that is emerging as a cardiovascular risk factor, also can produce oxidative stress (28).”
BackgroundSelf-citationGlycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
Saisho, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018381 · Cited by 195
“worsened endothelial function, which was further worsened by hyperglycemia after hypoglycemia [76].”
BackgroundGlycaemic management in diabetes: old and new approaches
Ceriello, A., Prattichizzo, F., Phillip, M., Hirsch, I. B., Mathieu, C., & Battelino, T. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00245-x · Cited by 139
Self-citationMartyn-Nemeth, P., Quinn, L., Penckofer, S., Park, C., Hofer, V., & Burke, L. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.12.015 · Cited by 128
Hypoglycemia in Type 2 Diabetes - More Common Than You Think: A Continuous Glucose Monitoring Study
Gehlaut, R. R., Dogbey, G. Y., Schwartz, F. L., Marling, C. R., & Shubrook, J. H. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815581052 · Cited by 131
Glucose Variability: How Does It Work?
Klimontov, V. V., Saik, O., & Korbut, A. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157783 · Cited by 142
“Nonetheless, in patients with the T1D, the J-index, a GV parameter, correlated negatively with CD34+ EPC count [77].”
BackgroundInfluentialPrattichizzo, F., De Nigris, V., La Sala, L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1810327 · Cited by 129
Self-citationHypoglycemia in Patients with Diabetes and Renal Disease
Alsahli, M., & Gerich, J. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050948 · Cited by 123
“There are theoretical, experimental and clinical considerations that suggest a causal effect, such as effects of hypoglycemia on oxidative stress, endothelial dysfunction, ST-segment prolongation and precipitation of arrhythmias via activation of the sympathetic nervous system [59,63,64].”
BackgroundAge- and glycemia-related miR-126-3p levels in plasma and endothelial cells
Olivieri, F., Bonafè, M., Spazzafumo, L., Gobbi, M., Prattichizzo, F., Recchioni, R., Marcheselli, F., Sala, L. L., Galeazzi, R., Rippo, M. R., et al. (2014) · Aging · doi:10.18632/aging.100693 · Cited by 118
Self-citationImmune aging in diabetes and its implications in wound healing
Moura, J., Madureira, P., Leal, E. C., Fonseca, A. C., & Carvalho, E. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.02.002 · Cited by 129
“Also, diabetic patients treated with antioxidant compounds show better immune and endothelial function [45].”
BackgroundCeriello, A., Testa, R., & Genovese, S. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.01.006 · Cited by 119
Self-citationJoy, N. G., Tate, D. B., Younk, L. M., & Davis, S. N. (2015) · Diabetes · doi:10.2337/db14-1729 · Cited by 99
Proinflammatory effects of hypoglycemia in humans with or without diabetes
Ratter, J. M., Rooijackers, H. M. M., Tack, C. J., Hijmans, A. G. M., Netea, M. G., de Galan, B. E., & Stienstra, R. (2017) · Diabetes · doi:10.2337/db16-1091 · Cited by 94
Dong, X., Zhao, S.-X., Yin, X., Wang, H., Wei, Z.-G., & Zhang, Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.111 · Cited by 97
Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review
Hanefeld, M., Duetting, E., & Bramlage, P. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-135 · Cited by 93
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era
Ceriello, A., Standl, E., Catrinoiu, D., Itzhak, B., Lalic, N. M., Rahelic, D., Schnell, O., Škrha, J., & Valensi, P. (2020) · Diabetes Care · doi:10.2337/dc20-0941 · Cited by 88
Self-citationLocation-specific risk factors for intracerebral hemorrhage: Systematic review and meta-analysis
Jolink, W. M. T., Wiegertjes, K., Rinkel, G. J. E., Algra, A., de Leeuw, F., & Klijn, C. J. M. (2020) · Neurology · doi:10.1212/wnl.0000000000010418 · Cited by 92
Glycemic Variability and CNS Inflammation: Reviewing the Connection
Watt, C., RANGEL, E. S., & Hwang, J. J. (2020) · Nutrients · doi:10.3390/nu12123906 · Cited by 95
“Moreover, inducing extremes in glucose levels such as a period of hypoglycemia followed by hyperglycemia was associated with worse endothelial function as well as greater oxidative stress and inflammation [71].”
BackgroundBlood Glucose Prediction With VMD and LSTM Optimized by Improved Particle Swarm Optimization
Wang, W., Tong, M., & Yu, M. (2020) · IEEE Access · doi:10.1109/access.2020.3041355 · Cited by 92
“Diabetes has a long course of disease, which is easy to cause damage to the tissues and organs of the whole body, resulting in disease and even death [2], [3].”
BackgroundLin, C.-C., Yang, C.-P., Li, C.-I., Liu, C.-S., Chen, C.-C., Lin, W.-Y., Hwang, K.-L., Yang, S.-Y., & Li, T.-C. (2014) · BMC Medicine · doi:10.1186/s12916-014-0165-7 · Cited by 80
Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.07.013 · Cited by 91
Glucose homeostasis, nutrition and infections during critical illness
Ingels, C., Vanhorebeek, I., & den Berghe, G. V. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.12.033 · Cited by 78
Bjornstad, P., Snell‐Bergeon, J. K., Rewers, M., Jalal, D. I., Chonchol, M. B., Johnson, R. J., & Maahs, D. M. (2013) · Diabetes Care · doi:10.2337/dc13-0631 · Cited by 72
“Annual screening for albuminuria and eGFR is recommended by the American Diabetes Association (35).”
BackgroundInfluentialKarstoft, K., Clark, M. A., Jakobsen, I., Müller, I. A., Pedersen, B. K., Solomon, T. P. J., & Ried‐Larsen, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4170-6 · Cited by 74
Bajaj, H. S., Venn, K., Ye, C., Patrick, A., Kalra, S., Khandwala, H., Aslam, N., Twum-Barima, D., & Aronson, R. (2017) · Diabetes Care · doi:10.2337/dc16-1582 · Cited by 65
Ceriello, A., Novials, A., Ortega, E., Canivell, S., La Sala, L., Pujadas, G., Bucciarelli, L., Rondinelli, M., & Genovese, S. (2013) · Diabetes Care · doi:10.2337/dc13-0750 · Cited by 65
“9 mmol/L) was achieved using a modification of the glucose clamp technique (16).”
MethodSelf-citationIs intensive glucose control bad for critically ill patients? A systematic review and meta-analysis
Yao, R.-Q., Ren, C., Wu, G., Zhu, Y., Xia, Z., & Yao, Y.-M. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.43447 · Cited by 70
Lespagnol, É., Dauchet, L., Pawlak‐Chaouch, M., Balestra, C., Berthoin, S., Feelisch, M., Roustit, M., Boissière, J., Fontaine, P., & Heyman, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00203 · Cited by 75
“Articles using needle injury methods were excluded because of additional contributions of the nervous system (21, 40).”
MethodBellis, A., Mauro, C., Barbato, E., Ceriello, A., Cittadini, A., & Morisco, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020775 · Cited by 61
“In particular, GLP-1 has anti-inflammatory and antiatherogenic properties [148,189–193], and it counterbalances oxidative stress induced by both hyperglycaemia and hypoglycaemia in T1DM [194].”
BackgroundSelf-citationEffects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes
Christou, M., Christou, P. A., Kyriakopoulos, C., Christou, G. A., & Tigas, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119357 · Cited by 71
Martyn‐Nemeth, P., Phillips, S. A., Mihailescu, D., Farabi, S. S., Park, C., Lipton, R., Idemudia, E., & Quinn, L. (2018) · Journal of Advanced Nursing · doi:10.1111/jan.13765 · Cited by 58
“GV has important clinical relevance because greater GV has been associated with endothelial dysfunction (a marker of early CVD), diabetes complications, cardiovascular events, and mortality (Ceriello et al., 2012; Quagliaro et al., 2003; Soupal et al., 2014; Yoon et al., 2016).”
Glucose Variability and Diabetic Complications: Is It Time to Treat?
Ceriello, A. (2020) · Diabetes Care · doi:10.2337/dci20-0012 · Cited by 66
“hypoglycemia might also be involved: hyperglycemia post-hypoglycemia is also an issue of GV, leading to a dangerous situation linked to the risk of CV complications (11).”
BackgroundSelf-citationImpact of occupational hearing loss on the lives of workers.
Hétu, R., Getty, L., & Quoc, H. T. (1995) · PubMed · Cited by 82
Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk
Jin, C., Li, G., Rexrode, K. M., Gurol, M. E., Yuan, X., Hui, Y., Ruan, C., Vaidya, A., Wang, Y., Wu, S., et al. (2017) · Stroke · doi:10.1161/strokeaha.117.019189 · Cited by 64
Mitochondrial regulation of diabetic vascular disease: an emerging opportunity
Widlansky, M. E., & Hill, R. B. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.015 · Cited by 66
Ohara, M., Nagaike, H., Goto, S., Fukase, A., Tanabe, Y., Tomoyasu, M., Yamamoto, T., Hayashi, T., Fukui, T., & Hirano, T. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.017 · Cited by 59
Issues for the management of people with diabetes and COVID-19 in ICU
Ceriello, A., Standl, E., Catrinoiu, D., Itzhak, B., Lalic, N. M., Rahelić, D., Schnell, O., Škrha, J., & Valensi, P. E. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01089-2 · Cited by 58
Self-citationCeriello, A., Novials, A., Ortega, E., Pujadas, G., Sala, L. L., Testa, R., Bonfigli, A. R., & Genovese, S. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.05.003 · Cited by 52
Self-citationHypoglycemia in diabetes: The dark side of diabetes treatment. A patient‐centered review
Johnson‐Rabbett, B., & Seaquist, E. R. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12933 · Cited by 55
Mo, Y., Lu, J., & Zhou, J. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14112 · Cited by 56
“40 carried out another noteworthy study comparing the recovery from a 2-h induced hypoglycemia followed by 2 h of normoglycemia or hyperglycemia, and then maintaining normal glycemia for the following 6 h.”
BackgroundLee, S. A., Cho, S. J., Jeong, M. H., Kim, Y., Kim, C. J., Cho, M., Kim, H.-S., Ahn, Y., Koh, G., Lee, J. M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2856 · Cited by 48
“after hypoglycemia was shown to cause more severe pathophysiologic changes than those observed during recovery to euglycemia, for a so-called “reperfusionlike effect” (38,39).”
BackgroundKajihara, N., Kukidome, D., Sada, K., Motoshima, H., Furukawa, N., Matsumura, T., Nishikawa, T., & Araki, E. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12678 · Cited by 47
The Impact of Hypoglycemia on the Cardiovascular System: Physiology and Pathophysiology
Yang, S., Park, K., & Zhou, Y.-J. (2015) · Angiology · doi:10.1177/0003319715623400 · Cited by 55
Hypoglycemia-Associated Autonomic Failure in Diabetes: Maladaptive, Adaptive, or Both?
Cryer, P. E. (2015) · Diabetes · doi:10.2337/db15-0331 · Cited by 43
Understanding the impact of hypoglycemia on the cardiovascular system
Davis, I., Ahmadizadeh, I., Randell, J., Younk, L. M., & Davis, S. N. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1275960 · Cited by 50
Diaw, M., Pialoux, V., Martin, C., Samb, A., Diop, S., Faës, C., Mury, P., Diop, N., Diop, S. N., Ranque, B., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0699 · Cited by 44
“Acute vitamin C infusion has been shown to improve FMD (34) and to limit the FMD impairment in response to hyperglycemia in patients with diabetes (35).”
BackgroundMcNeilly, A. D., Gallagher, J. R., Dinkova‐Kostova, A. T., Hayes, J. D., Sharkey, J., Ashford, M. L. J., & McCrimmon, R. J. (2016) · Diabetes · doi:10.2337/db15-1653 · Cited by 41
Gauer, J. S., Ajjan, R., & Ariëns, R. A. S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027071 · Cited by 50
Klimontov, V. V., Bulumbaeva, D. M., Fazullina, O. N., Lykov, A. P., Bgatova, N. P., Орлов, Н. Б., Konenkov, V. I., Pfeiffer, A. F. H., Pivovarova‐Ramich, O., & Rudovich, N. N. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00536-4 · Cited by 38
“The associations between levels of acute phase proteins and glucose variability parameters in type 2 diabetic subjects were also reported (Chang et al. 2012; Klimontov et al. 2016a, b).”
BackgroundYu, M., Xie, R., Zhang, Y., Liang, H., Hou, L., Yu, C., Zhang, J., Dong, Z., Tian, Y., Bi, Y., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy027 · Cited by 36
Prognostic value of endothelial dysfunction in type 1 diabetes mellitus
Ladeia, A. M. T., Sampaio, R. R., Hita, M. C., & Adan, L. F. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i5.601 · Cited by 43
Clinical features and therapeutic perspectives on hypertension in diabetics
Katayama, S., Hatano, M., & Issiki, M. (2018) · Hypertension Research · doi:10.1038/s41440-017-0001-5 · Cited by 39
Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles
Tanner, M. J., Wang, J., Ying, R., Suboc, T. M. B., Malik, M. A., Couillard, A. B., Branum, A., Puppala, V. K., & Widlansky, M. E. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00499.2016 · Cited by 34
Diabetic Kidney Disease: Is There a Role for Glycemic Variability?
Subramanian, S., & Hirsch, I. B. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0979-3 · Cited by 35
Treatment of Hypoglycemia in Adult Patients with Type 1 Diabetes: An Observational Study
Savard, V., Gingras, V., Leroux, C., Bertrand, A., Desjardins, K., Mircescu, H., & RABASA-LHORET, R. P. R. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.05.008 · Cited by 44
Kato, A., Tatsumi, Y., Yako, H., Sango, K., Himeno, T., Kondo, M., Kato, Y., Kamiya, H., Nakamura, J., & Kato, K. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.11.004 · Cited by 33
Sala, L. L., Crestani, M., Garavelli, S., de Candia, P., & Pontiroli, A. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010143 · Cited by 30
David, M., & Kartheek, R. M. (2015) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-5286-9 · Cited by 32
Domínguez‐Luis, M. J., Armas‐González, E., Herrera-García, A., Arce-Franco, M. T., Feria, M., Vicente‐Manzanares, M., Martínez-Ruiz, A., Sánchez‐Madrid, F., & Díaz‐González, F. (2018) · European Journal of Immunology · doi:10.1002/eji.201847710 · Cited by 32
Fysekidis, M., Cosson, E., Banu, I., Duteil, R., Cyrille, C., & Valensi, P. E. (2014) · Metabolism · doi:10.1016/j.metabol.2014.09.006 · Cited by 33
Antioxidant effects of epigallocatechin-3-gallate on the aTC1-6 pancreatic alpha cell line
Cao, T., Xiong, Z., Yang, D., Wang, Y.-Q., Qiao, Z., Huang, J., & Zhang, P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.006 · Cited by 29
Qi, L., Geng, X., Feng, R.-L., Wu, S., Fu, T., Li, N., Ji, H., Cheng, R., Wu, H., Wu, D., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111869 · Cited by 35
Chiang, J., Li, T., Li, C. I., Liu, C. S., Meng, N.-H., Lin, W., Yang, S., Chen, H.-J., & Lin, C. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3689-1 · Cited by 27
Momozono, A., Kodera, Y., Sasaki, S., Nakagawa, Y., Konno, R., & Shichiri, M. (2020) · Scientific Reports · doi:10.1038/s41598-019-57095-2 · Cited by 25
Diabetes and Vascular Disease: Is It All About Glycemia?
Vecchié, A., Montecucco, F., Carbone, F., Dallegri, F., & Bonaventura, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190830181944 · Cited by 24
Joy, N. G., Mikeladze, M., Younk, L. M., Tate, D. B., & Davis, S. N. (2016) · Metabolism · doi:10.1016/j.metabol.2016.09.001 · Cited by 24
“There are only a few studies reporting the effects of hypoglycemia on fibrinolytic/coagulation mechanisms in healthy and type 1 diabetes individuals [28, 29, 36], but no data reporting these effects during hypoglycemia in type 2 diabetic humans.”
BackgroundCeriello, A., Novials, A., Ortega, E., Canivell, S., Pujadas, G., Sala, L. L., Bucciarelli, L. G., Rondinelli, M., & Genovese, S. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-97 · Cited by 24
Self-citationLee, C., Hsieh, M., Chang, S., Hung, K., Wang, C., Hsu, M., Juang, J., Hsieh, I.-C., Wen, M., & Liu, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s211898 · Cited by 22
Wang, Y., Hall, L. M., Kujawa, M., Li, H., Zhang, X., O’Meara, M., Ichinose, T., & Wang, J. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00117.2018 · Cited by 20
“Hyperglycemia is an important player in endothelial dysfunction through induction of oxidative and inflammatory stress (8, 39).”
BackgroundUrbano, F., Farella, I., Brunetti, G., & Faienza, M. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511980 · Cited by 25
“T1D impairs endothelial function since childhood; in particular, the glucose variability can increase the vascular proliferation of smooth muscle cells, whereas hyperglycemia and the increase in fatty acid levels enhance oxidative stress and the production of advanced glycation end products [81,82].”
BackgroundHarrington, J., Peña, A. S., Wilson, L., Gent, R. J., Dowling, K., Baghurst, P., & Couper, J. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12050 · Cited by 21
“In T1D, fluctuations in glucose concentrations following hypoglycaemia have been linked to endothelial dysfunction (30).”
BackgroundLiao, L.-N., Li, C., Liu, C.-S., Huang, C., Lin, W., Chiang, J., Lin, C., & Li, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130828 · Cited by 19
Glucose variability predicts 6-month mortality in patients hospitalized with acute heart failure
Cunha, F. M., Cidade-Rodrigues, C., Elias, C., Oliveira, D., Bettencourt, P., & Lourenço, P. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02719-7 · Cited by 21
Darvishi, B., Dinarvand, R., Mohammadpour, H., Kamarul, T., & Sharifi, A. M. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00248 · Cited by 17
Ohara, M., Hiromura, M., Nagaike, H., Kohata, Y., Fujikawa, T., Goto, S., Sato, N., Kushima, H., Terasaki, M., Yamamoto, T., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107904 · Cited by 18
McNeilly, A. D., Gallagher, J. R., Evans, M. L., de Galan, B. E., Pedersen‐Bjergaard, U., Thorens, B., Dinkova‐Kostova, A. T., Huang, J. T.-J., Ashford, M. L. J., & McCrimmon, R. J. (2023) · Diabetologia · doi:10.1007/s00125-023-05907-6 · Cited by 18
Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes
Katsiki, N., Kotsa, K., Stoian, A. P., & Mikhailidis, D. P. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200909142658 · Cited by 16
Nitrones reverse hyperglycemia-induced endothelial dysfunction in bovine aortic endothelial cells
Headley, C. A., DiSilvestro, D. J., Bryant, K. E., Hemann, C. F., Chen, C., Das, A. K., Ziouzenkova, O., Durand, G., & Villamena, F. A. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.01.005 · Cited by 18
“Increased ROS production results in decrease in NO bioavailability due to its sequestration by O2 •− and/or decreased expression of eNOS [34], impaired glucose metabolism [35] and insulin resistance in metabolic tissues [36] resulting in eNOS uncoupling, increased advanced glycation product formation in tissues [37],…”
Dong, X., Guan, F., Xu, S., Zhu, L., Zhang, P., Cheng, A., & Liu, T. (2018) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.223951 · Cited by 15
He, A., Hu, S., Pi, Q., Guo, Y., Long, Y., Luo, S., & Xia, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-76340-7 · Cited by 15
Insulin actions on hypothalamic glucose‐sensing neurones
Garcia, S. M., Hirschberg, P. R., Sarkar, P., Siegel, D. M., Teegala, S. B., Vail, G. M., & Routh, V. H. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12937 · Cited by 18
Issar, T., Tummanapalli, S. S., Kwai, N. C. G., Chiang, J. C. B., Arnold, R., Poynten, A. M., Markoulli, M. P., & Krishnan, A. V. (2020) · Diabetic Medicine · doi:10.1111/dme.14306 · Cited by 16
Batule, S., Ramos, A., Pérez-Montes de Oca, A., Fuentes, N., Martínez, S., Raga, J., Pena, X., Tural, C., Muñoz, P., Soldevila, B., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102813 · Cited by 13
BAJAJ, H. S., Aljabri, B. A., & Verma, S. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000562 · Cited by 14
Martyn-Nemeth, P. A., Duffecy, J. L., Quinn, L., Park, C., Mihailescu, D. V., & Penckofer, S. M. (2019) · Trials · doi:10.1186/s13063-019-3876-4 · Cited by 16
Can Resistance Exercise Be a Tool for Healthy Aging in Post-Menopausal Women with Type 1 Diabetes?
Momeni, Z., Logan, J. E., Sigal, R. J., & Yardley, J. E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168716 · Cited by 35
Lee, C., Hsieh, M., Roth, J. G., Fu, X., Lu, C., Hung, K., Kuo, C., & Liu, S. (2022) · ACS Applied Polymer Materials · doi:10.1021/acsapm.2c00186 · Cited by 11
Stojanović, I. R., Djordjević, G., Pavlović, R., Djordjević, V. B., Pavlovic, D. D., Cvetković, T., Ljubisavljević, S., Bašić, J., & Zabar, K. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.09.026 · Cited by 11
“The increase of RSNOs might be related to protein glycation that favors nitrosylation of protein thiols byNO [33].”
BackgroundPerea, V., Bertran, B., Bellart, J., Orois, A., Giménez, M., Conget, I., & Vinagre, I. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3176 · Cited by 11
Intensive Glucose Control and Type 2 Diabetes — 15 Years On
Reaven, P. D., Hayward, R. A., & Zhou, J. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1909041 · Cited by 11
Megson, I. L., Treweeke, A. T., Shaw, A., MacRury, S. M., Setford, S. J., Frías, J. P., & Anhalt, H. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815570359 · Cited by 10
Thomson, M., Al‐Qattan, K. K., Divya, J. S., & Ali, M. (2013) · International Journal of Pharmacology · doi:10.3923/ijp.2013.501.512 · Cited by 11
Predictors of consciousness improvement in patients with hypoglycemic encephalopathy
Lee, Y. E., Lee, E. J., Lee, S. E., & Park, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.956367 · Cited by 11
“Post-treatment hyperglycemia was defined as serum glucose greater than 200mg/dL for 2 hours post-treatment based on previous studies (10, 11).”
MethodLiu, A., Fan, Z., Lu, X., Wu, Y., Zhao, W., Lou, X., Hu, J.-H., & Peng, X. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.977278 · Cited by 9
“What’ more, there is evidence that the hyperglycemia after recovery from hypoglycemia leads to worsened endothelial function, increased oxidative stress and inflammation in both healthy individuals and the diabetic (36).”
Background
Metadata
- Authors
- Ceriello, A., Novials, A., Ortega, E., La Sala, L., Pujadas, G., Testa, R., Bonfigli, A. R., Esposito, K., & Giugliano, D.
- Affiliations
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Department of Endocrinology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Hospital Clínic de Barcelona (ES)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Corresponding author
- Ceriello, Antonio
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-10-16
- Volume
- 61
- Issue
- 11
- Pages
- 2993-2997
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3478543
- OpenAlex
- W2107614741
- Cited by
- 155
- References
- 25
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 11 · 2022: 9 · 2021: 16 · 2020: 17 · 2019: 14 · 2018: 12 · 2017: 10 · 2016: 14 · 2015: 12 · 2014: 14 · 2013: 9 · 2012: 2
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hypoglycemia, hyperglycemia, endothelial dysfunction, oxidative stress, inflammation, type 1 diabetes, vitamin C, ischemia-reperfusion, atherosclerosis risk, cardiovascular risk factors
- MeSH terms
- Adult, Antioxidants, Ascorbic Acid, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Endothelium, Vascular, Female, Glucose, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Infusions, Intravenous, Insulin, Male, Risk Factors, Vasodilation, Oxidative Stress, Cross-Over Studies, Inflammation Mediators, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.